Form 8-K - Current report:
SEC Accession No. 0000921895-18-002519
Filing Date
2018-08-31
Accepted
2018-08-31 16:15:22
Documents
2
Period of Report
2018-08-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k11577002_08312018.htm 8-K 16638
2 ex101to8k11577002_08312018.htm EX-10.1 120053
  Complete submission text file 0000921895-18-002519.txt   138129
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 181050312
SIC: 2834 Pharmaceutical Preparations